|
|
|
|
219 * !
|
Wed, 8/11/2021,
10:00 AM -
11:50 AM
|
Virtual
|
|
Artificial Intelligence and Machine Learning in Medical Imaging for Drug Development — Invited Papers
|
|
Section on Statistics in Imaging, Section on Medical Devices and Diagnostics, Biopharmaceutical Section
|
|
Organizer(s): Bushi Wang, Boehringer Ingelheim Pharmaceuticals Inc.
|
|
Chair(s): Sue-Jane Wang, FDA
|
|
10:05 AM
|
Using Deep Learning on HRCT Scan to Predict Pulmonary Fibrosis Progression and Support Early Clinical Development Decision
Bushi Wang, Boehringer Ingelheim Pharmaceuticals Inc.; Yi Liu, Boehringer Ingelheim; Hao Li, Boeringer-Ingelheim
|
|
10:25 AM
|
Application of Machine Learning in Medical Imaging: Overview of Novartis Radiomics Projects
Thibaud Coroller, Novartis
|
|
10:45 AM
|
Histopathology and AI for Cancer Subtype and Mutation Detection
Narges Razavian, New York University Langone Health
|
|
11:05 AM
|
Development and Clinical Evaluation of Quantitative Lung Fibrosis Scores on CT Images in Clinical Trials: Idiopathic Pulmonary Fibrosis and Scleroderma Lung Disease
Grace Hyun Kim, UCLA; Jonathan Goldin, UCLA; Matthew Brown, UCLA
|
|
11:25 AM
|
Recent Advances in Machine Learning in Medical Image Analysis
Fei Wang, Weill Cornell Medicine
|
|
11:45 AM
|
Floor Discussion
|
